FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status:
Terminated
Trial end date:
2010-06-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy of FST-100 (PVP-I 0.4% and
dexamethasone 0.1%) Ophthalmic Suspension in the treatment of suspected acute adenoviral
conjunctivitis.